CancerIQ, a Chicago, IL-based precision health platform that empowers healthcare providers to personalize cancer prevention and early detection for their patients, received a revenue based financing from Decathlon Capital Partners.
The amount of the deal was not disclosed.
The company intends to use the funds to invest in platform development, the introduction of new offerings, and support growth with health system and hospital partnerships.
Led by CEO Feyi Olopade Ayodele, CancerIQ is a cancer-focused precision health platform that empowers healthcare providers to detect cancer earlier and prevent it altogether across all patient populations. Integrated directly into real-time EHR workflows, it makes it easy for users to gather comprehensive patient data, automatically map it to the latest evidence-based guidelines, and expand access to personalized care plans, clinical solutions, and genomic innovations.
FinSMEs
26/08/2024